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Globally diabetes mellitus is a significant problem with an
estimated 140 million diseased individuals worldwide,
expected to increase to 300 million by the year 2025.1 South
Africa is not spared from this chronic disease and has an
estimated prevalence of between 5.3% and 8.0% among
urbanised populations.2-4
According to the World Health Organisation (WHO) diabetes
is the fourth largest underlying cause of death, and is strongly
associated with cardiovascular disease.1 Hypertension is a
common co-morbidity for diabetes in South Africa, and
contributes significantly to morbidity related to diabetes.5-7
It is therefore very important to optimise the care of diabetic
patients at primary secondary and tertiary care level.
Numerous clinical practice guidelines for management of
diabetes have been compiled and circulated to health care
workers, but despite this the level of diabetes care is still not
ideal because of suboptimal implementation strategies.
Guideline implementation problems are a significant problem
in South Africa, as described in the study by Levitt et al.8 who
studied and attempted to improve the quality of diabetes care
in primary care clinics in Cape Town. However this is not only
a local problem, as evidenced by numerous international
studies indicating suboptimal and varied implementation of
guidelines.9
This study attempts to describe and test a model to improve
the quality of diabetes care in a tertiary care diabetes clinic. The
model includes a physician training programme and a
structured consultation schedule based on the South African
guidelines for diabetes care.10
Methods
Approval for conducting this study was obtained from the
Research Ethics Committee of the Faculty of Health Sciences of
the University of Pretoria. Informed consent was obtained from
all patients and doctors taking part in this study.  
This study had a quasi-experimental controlled before-and-
after design, comparing two clinics at the same tertiary care
institution (Kalafong Hospital). 
Both clinics were initially audited cross-sectionally to acquire
baseline data on quality of patient care. The average
455
June 2004, Vol. 94, No. 6  SAMJ
Physician education programme improves quality of
diabetes care
D G van Zyl, P Rheeder
Background. Diabetes mellitus is a common chronic disease
needing long-term glycaemic control to prevent
complications. Guidelines are available for achievement of
optimal glycaemic control, but these are seldom properly
instituted.
Objectives. To determine if a physician education programme
and a structured consultation schedule would improve the
quality of diabetes patient care in a diabetes clinic.
Setting. Two tertiary care diabetes clinics at Kalafong
Hospital, Pretoria.
Study design. Quasi-experimental controlled before-and-after
study.
Methods. A baseline audit of the quality of care in two
comparable diabetes clinics was performed. Three hundred
patients were randomly selected for audit of their hospital
records: 141 from the intervention and 159 from the control
clinics. Thereafter a physician training programme and a
structured consultation schedule were introduced to the
intervention clinic and maintained for a 1-year period. The
control clinic continued with care as usual. Process and
outcome measures were determined at a post-intervention
audit and compared between the two groups. Consultation
time was measured for both the intervention and control
groups and data were compared.
Results. At baseline the intervention and control groups did
not differ significantly with regard to process and outcome
measures. After intervention the intervention group had
significantly higher process measure scores than the control
group (p < 0.01). HbA1c did not significantly differ between
the two groups (p = 0.60). The average number of clinic visits
reduced over time for the intervention group compared with
the control group (p < 0.01), but the average consultation
times were significantly longer (p < 0.01).
Conclusion. The introduction of a physician education
programme and a structured consultation schedule improved
the quality of care delivered at a tertiary care diabetes clinic.
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consultation time was measured at the same time at baseline.
An intervention, which included a structured consultation
schedule and a physician education programme, was
introduced in one of the clinics. The other clinic functioned as
the control against which the efficacy of the intervention was
measured. A second audit, at the end of the 1-year intervention
period, was done to determine the efficacy of the intervention.
Patients attending and doctors working in either of the clinics
were not allowed to cross over to the other clinic. Both clinics
utilised the same nursing staff and the same premises. The
medical staff for the two clinics consisted of a specialist
physician, a senior registrar and two medical officers each. 
Structured consultation schedule and physician
training programme
Both the training programme and the structured patient care
schedule were based on the Society for Endocrinology,
Metabolism and Diabetes of South Africa (SEMDSA) guidelines
for the management of type 2 diabetes (the most recent South
African guidelines available at the time of this study).10 All
procedures and special investigations were planned for this
study according to these clinical practice guidelines.
An interactive training programme was introduced for all
doctors working in the intervention diabetes clinic.  This
consisted of quarterly non-compulsory training sessions. These
sessions included theoretical knowledge transfer as well as
discussion of practical aspects of outpatient diabetes care.
Topics included glycaemic control in type 1 and type 2
diabetes, prevention and diagnosis of diabetic foot problems,
diagnosis and prevention of diabetic eye problems, risk
reduction of macrovascular disease in diabetic patients, micro-
albuminuria, and educating the diabetic patient on diabetes
care. A training session was held before each section of the
structured consultation schedule and specifically addressed
issues related to that section.
In the intervention clinic, diabetes care was changed from
the previous independent approach (where each doctor saw
patients without constraints, and decided on examinations and
special investigations alone), to a structured approach. This
was accompanied by a standardised easy-to-complete clinical
record form. The structured approach aimed to make the care
more homogeneous. Each patient was scheduled to attend the
clinic quarterly, with a different focus at each visit. The first
quarterly visit focused on foot care with a proper foot
examination and patient education on foot care. An HbA1c test
was also done at this visit. During the second quarterly visit
patients received education on their medication and the
importance of regular use thereof. Each patient was also
referred to the dietician, their body mass index was calculated,
and advice was given with regard to obesity and
cardiovascular risk factors. Each patient had a urine test for
micro-albuminuria, a lipid profile, a serum creatinine and an
HbA1c test during the third quarterly visit.  The fourth
quarterly visit focused on eye problems. Visual acuity was
measured and direct fundoscopy done for each patient, or the
patient was referred to an ophthalmologist. An ECG was also
done during the fourth visit. 
Audit of patient records
Consent for auditing of clinical records was obtained from 300
randomly selected patients, 141 from the intervention and 159
from the control clinics. Patients were numbered according to
arrival at the clinic. Random numbers were obtained from a
random number website, and patients corresponding to the
random numbers were approached for inclusion in the study
audits. An independent person with a thorough knowledge of
diabetes audited all hospital records at baseline and 1 year
later.
The patient records were assessed for evidence of the
following process measures, which ought to have been done
according to the SEMDSA guidelines:  a foot examination, an
eye examination, a urine test for micro-albuminuria, dietary
counselling, an HbA1c test, and a lipid profile during the 12
months preceding each audit. A score was calculated from
these six process measures (each process measure counting one
point) for each patient at the baseline and post-intervention
audits. The main outcome measure was the HbA1c value.
HbA1c values of more than 9.5% were considered to indicate
poor glycaemic control, less than 7.5% good control, and all
values in between moderate control.
In addition the following were noted from the patient
records: admissions to hospital and the number of clinic visits
during the past 12 months as well as current therapy of
patients.
Statistical analysis
Statistical analysis was performed using the SPSS statistical
package. The Mann-Whitney and Wilcoxon’s non-parametric
tests were used for comparison of the number of clinic visits
and number of hospitalisations between the study and control
groups. Chi-square tests were done for comparison of variables
with nominal frequencies . Process measure scores and other
continuous data variables done repeatedly were analysed
utilising the repeated measures analysis of variance (ANOVA)
test. The consultation times at different visits were compared
between the intervention and control groups as well as in
relation to baseline, where an ANOVA test was done.  A two-
sided p-value of < 0.05 was considered significant. 
Results
Patient demographics
At baseline there were no statistically significant differences
between the intervention and control clinics with regard to
patient demographics (Table I).
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Clinic visits
The mean number of clinic visits for the intervention group at
baseline was 4.97 per year (median 5.00, range 1 - 9). After the
intervention this dropped to 3.7 visits per year (median 4,
range 1 - 6) (p < 0.01). In the control group the mean number of
clinic visits per year at baseline was 4.7 (median 5.0, range 
1 - 11); post intervention this dropped non-significantly to
mean 4.2 (median 4.00, 1 - 9) (p = 0.13). Over the 1-year time
period from the baseline to the post-intervention audit a
significant difference in the number of clinic visits was noted
between the intervention and control groups (p < 0.01). 
Process measures
At baseline no statistical difference in the mean process
measure score could be demonstrated between the intervention
and control groups (p = 0.99). After intervention the
intervention group clearly scored better than the control group
(p < 0.01). 
Both the intervention and control groups showed an
improvement in the average number of process measures
patients received from baseline at the post-intervention audit,
but only that of the intervention group was statistically
significant (intervention group: p < 0.01, control group: 
p = 0.08) (Table II).
A repeated measures ANOVA test indicated a significant
change in scores between the two groups over time (p < 0.01)
(Fig. 1).
HbA1c
The mean of the last HbA1c tests done before the baseline audit
for both the intervention and control groups did not differ
significantly (9.77% and 10.27% respectively, p = 0.31). Post
intervention, although an improvement in the mean HbA1c
occurred in both the intervention and control groups, the
difference between them was not significant (8.5% and 9.15%
respectively, p = 0.14) (Table III). The HbA1c change over time
between the intervention and control groups did not differ
significantly (p = 0.60).
The proportion of patients with poor glycaemic control
diminished in both the intervention (from 47.4% to 36.8%) and
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Table I.  Patient demographics for the intervention and
control groups at baseline
Intervention Control
Variable N (%) N (%) p-value
Number 141 (47) 159 (53)
Treatment
Oral 69 (48.9) 91 (57.2)
Insulin 43 (30.5) 42 (26.4) 0.34 
Combination 29 (20.6) 26 (16.4)
Male 52 (36.8) 57 (35.8) 0.67
Age (years)
(mean (SD)) 56.38 (13.00) 54.72 (14.46) 0.30
Duration of 
diabetes (mean (SD)) 10.36 (7.47) 9.82 (7.72) 0.54
Table II. Comparison of process measures at baseline and after intervention for the intervention and control groups
Intervention Control
N = 141 (%) N = 159 (%)
Parameter Baseline After intervention p-value Baseline After intervention p-value
Foot examination 33 (23.4) 126 (89.4) < 0.01 58 (36.5) 78 (49.1) 0.04
Eye examination 45 (31.9) 99 (70.2) < 0.01 63 (39.6) 32 (20.1) < 0.01
Test for micro-albuminuria 20 (14.2) 103 (73) < 0.01 15 (9.4) 24 (15.1) 0.16
HbA1c test 91 (65.5) 133 (94.3) < 0.01 66 (41.5) 114 (71.7) < 0.01
Lipid profile 29 (20.6) 99 (70.2) < 0.01 24 (15.1) 54 (34) < 0.01
Dietician visit 28 (19.8) 89 (63.1) < 0.01 51 (32.1) 22 (13.8) < 0.01
Score (mean (SD)) 1.74 (1.53) 4.60 (1.48) < 0.01 1.74 (1.59) 2.04 (1.38) 0.08
Fig. 1. Profile plot indicating the change in mean scores from the
baseline to post-intervention audit.
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control groups (from 54.1% to 39.4%). The proportion of
patients with good glycaemic control improved non-
significantly in both the intervention group (from 32.6% to
39.6%, p = 0.17) and in the control group (from 25.2% to 37.9%,
p = 0.06).
Consultation time
The difference in mean duration of consultations measured at
various points for both the intervention and control groups
indicated a significant difference in consultation time between
the two groups (p < 0.01), with consultations in the
intervention group (15.6 minutes) significantly longer than
those in the control group (13.3 minutes). 
Discussion
This was a physician-driven study, investigating the quality of
diabetes care at the diabetes clinics of a tertiary care hospital.
Quality of diabetes care was assessed before and after the
implementation of measures aimed at improving the quality of
care rendered, as well as in comparison with a control group
without measures to improve the quality of care.
The care as indicated by certain process measures improved
significantly from baseline and in comparison with the control
group. It therefore seems that the intervention, which included
a physician training programme and the introduction of a
structured consultation schedule, was effective in improving
the quality of care delivered to diabetic patients.
This intervention also seems to improve the glycaemic
control of patients over time, although this was not statistically
significant. Furthermore, the proportion of patients with
uncontrolled diabetes decreased and the proportion of patients
with good glycaemic control increased.
Data from the baseline audit of this study compare very
poorly with those of audits related to the quality of diabetes
patient care elsewhere in the world, where more than 70% of
patients had HbA1c levels measured annually, 40 - 90% of
patients received foot examinations every year, and more than
50% underwent an annual eye examination.11-14 After
intervention the intervention group compared very favourably
with the quality of care delivered elsewhere in the world, e.g.
94% received a HbA1c test, 89.4% underwent a foot
examination and 70.2% had an eye examination (Table II). The
quality of care as measured by process measures compared
well with that of a primary health care record review done in
Cape Town in 1996,15 which indicated that only 6% of patients
received a fundoscopic eye examination and 4.7% a foot
examination.
Glycaemic control of patients in the intervention group
compared well with that of patients in a large urban hospital in
the USA, with 36.8% versus 31 - 43% of patients having
uncontrolled blood glucose levels (HbA1c > 9.5%).
14
Glycaemic control reported in other South African studies
seems to be comparable with glycaemic control at baseline of
this study (Table III).  Motala et al. report a mean HbA1c of 
9.8 ± 2.2% in an urban diabetes population with diabetes of
more than 10 years’ duration.7 Rotchford and Rotchford6
reported that in a rural diabetic population in KwaZulu-Natal
only 22.5% of patients had an HbA1c level of less than 8%.
Acceptable glycaemic control (HbA1c < 10%) was reported to
be present in 49.4% of patients partaking in an audit done in
Cape Town by Levitt et al.5
What is clearly different from the abovementioned USA
hospital diabetes clinics is the number of patient visits, which
on average varies between 8 and 15 visits per year.16-18 This
markedly exceeds that at the two Kalafong diabetes clinics
(median 4 - 5 visits per year) but seems less than the mean
number of clinic visits reported in two other South African
studies (9.5 ± 12.1 and 9.5 ± 3.4).5,6
Quasi-experimental studies are the most commonly used
designs in guideline implementation studies where there are
practical and ethical barriers to the conduction of randomised
controlled trials.19 This study fulfilled the requirements of a
controlled before-and-after design. Firstly, the study and
control groups should have the same baseline characteristics
and performance. In this study the intervention and control
groups did not differ significantly with regard to baseline
patient and clinic characteristics. Similarly with regard to
outcome and process measures the intervention and control
groups did not differ significantly at baseline.
Secondly, all other factors should be the same for both the
intervention and control groups except for the intervention
under investigation. During this study the nursing staff and all
facilities remained the same for both the intervention and
control groups. Thirdly, data should be collected at the same
time for both groups before and after the intervention. All data
were collected for both the intervention and control groups
simultaneously at baseline and after intervention. The same
person collected the data at baseline for both groups and after
intervention for both groups. Fourthly, between-group analysis
should be done comparing the study and control groups
following the intervention. This was done for this study, and
Table III. Between-group  and within-group comparison
of HbA1c at baseline and after intervention
Baseline After intervention
mean HbA1c (SD) mean HbA1c (SD) p-value*
Intervention 9.77 (3.36) 8.481 (2.60) < 0.01
Control 10.27 (3.60) 9.153 (3.28) 0.06
p-value† 0.31 0.14
*p-values for within-group comparisons (baseline v. after intervention).
†p-values for between-group comparisons (intervention v. control groups).
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therefore the differences can be assumed to be due to the
intervention.
An attempt to reduce bias was made throughout the study.
Firstly, both the intervention and control groups were
randomly selected for record auditing in an attempt to reduce
selection bias, which is evident in the absence of significant
differences in baseline parameters. Secondly, the two groups
were kept separate as far as possible and patients in the
intervention clinic were not allowed to change to the control
clinic and vice versa. Thirdly, all doctors attending to diabetes
patients were blinded as to which patients were selected for
record auditing in an attempt not to influence the quality of
care of patients selected for record auditing. Confounding by
means of the Hawthorne effect (the non-specific beneficial
effect of taking part in research) could not be prevented since
all doctors taking care of diabetic clinic patients knew that they
were being studied and signed informed consent. This might
explain why the control clinic also showed improvement in the
care and outcome measures, although to a lesser degree.
A limited number of measures was utilised to assess the
quality of diabetes care in the two clinics studied, but more
outcome measures, especially blood pressure, body mass index
and low-density lipoprotein (LDL) cholesterol, could have
aided in a more comprehensive assessment of patient outcome.
Other than process measures and outcome measures, measures
of patient education received in the diabetes clinics would also
have been useful in the assessment of comprehensive patient
care. However this would be much more difficult to measure.
In conclusion, this study provides evidence that a structured
consultation schedule and a physician education programme
improved the quality of diabetes care at a tertiary care diabetes
clinic. However this improvement in quality of care comes at
the expense of prolonged consultation time.
We thank the doctors at the two diabetes clinics, and M Loock
for auditing diabetes patient files.
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